• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of new oral cancer treatment as molecular target for antiapoptosis protein and NF-kB

Research Project

Project/Area Number 21592556
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Surgical dentistry
Research InstitutionThe University of Tokushima

Principal Investigator

TAMATANI Tetsuya  徳島大学, 病院, 講師 (30274236)

Co-Investigator(Kenkyū-buntansha) MIYAMOTO Youji  徳島大学, 大学院・ヘルスバイオサイエンス研究部, 教授 (20200214)
NAGAI Hirokazu  徳島大学, 大学院・ヘルスバイオサイエンス研究部, 准教授 (50282190)
UCHIDA Daisuke  徳島大学, 大学院・ヘルスバイオサイエンス研究部, 助教 (20335798)
MOGI Katsumi  徳島大学, 大学院・ヘルスバイオサイエンス研究部, 助教 (20335805)
Project Period (FY) 2009 – 2011
Project Status Completed (Fiscal Year 2011)
Budget Amount *help
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2011: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2010: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2009: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Keywords臨床腫瘍学 / 抗アポトーシス蛋白 / NF-κB / 分子標的
Research Abstract

XIAP is a member of the inhibitor of apoptosis protein family, which is associated with cell survival by blocking caspase-mediated apoptosis. XIAP is expressed in various malignant tumors. The overexpression of XIAP has been reported to be a poorer prognostic factor in various malignancies. present study were to evaluate the expression of XIAP protein in oral squamous cell carcinoma(OSCC) and to elucidate the relationships among the XIAP expression, clinical stages, histological differentiation and classification of invasion mode. human OSCC cell lines were used in this study. Normal gingival epithelial cells served as control. XIAP, cIAPs and survivin expressions of cultured cells wert detected by western blot. Tissue specimens were obtains from 85 patients with OSCC after surgery or biopsy. Their expression was detected by an immunohistochemical method. The expression of those proteins was detected in all cancer cells, but not in normal cells. Immunohistochemical analysis of 85 cases of OSCC showed that 73(86%) cases expressed XIAP. There was no relationship between XIAP expression and clinical stages, or classification of invasion mode. There were significant differences between XIAP expression and histological differentiation. Most of non-staining and weakly staining of cancer was well differentiated. In contrast, intense and extensive staining was frequently found in poorly differentiated cancer.

Report

(4 results)
  • 2011 Annual Research Report   Final Research Report ( PDF )
  • 2010 Annual Research Report
  • 2009 Annual Research Report
  • Research Products

    (6 results)

All 2011 2010 2009

All Presentation (6 results)

  • [Presentation] The expression of survivin in human oral squamous cell carcinomaand its relationship with clinical factors2011

    • Author(s)
      玉谷哲也
    • Organizer
      AACR 102nd annual meeting, Orange county convention Center
    • Place of Presentation
      Orlando, USA
    • Year and Date
      2011-04-02
    • Related Report
      2011 Final Research Report
  • [Presentation] The expression of survivin in human oral squamous cell carcinoma and its relationship with clinical factors2011

    • Author(s)
      玉谷哲也
    • Organizer
      AACR 102nd annual meeting
    • Place of Presentation
      Orange county convention Center, (Orlando, USA)
    • Year and Date
      2011-04-02
    • Related Report
      2011 Annual Research Report
  • [Presentation] 口腔扁平上皮癌におけるsurvivinの発現に関する検討2010

    • Author(s)
      玉谷哲也
    • Organizer
      第47回口腔組織培養学会学術大会
    • Place of Presentation
      高知城ホール(高知市)
    • Year and Date
      2010-11-13
    • Related Report
      2011 Final Research Report
  • [Presentation] Increased anti-tumor effects of sequential docetaxel followed by 5-FUtreatment against human oral cancer cells2010

    • Author(s)
      玉谷哲也
    • Organizer
      AACR 101nd annual meeting
    • Place of Presentation
      Washington D. C. USA
    • Year and Date
      2010-04-20
    • Related Report
      2011 Final Research Report
  • [Presentation] Increased anti-tumor effects of sequential docetaxel followed by 5-FU treatment against human oral cancer cells2010

    • Author(s)
      Tetsuya Tamatani, et al.
    • Organizer
      101st American association cancer research annual meeting
    • Place of Presentation
      Washington D.C.
    • Year and Date
      2010-04-20
    • Related Report
      2010 Annual Research Report
  • [Presentation] Anti-tumor efficacy of sequential treatment with docetaxel and 5-FU combination therapy against human oral cancer cells2009

    • Author(s)
      Tarannum Ferdous, 他
    • Organizer
      第67回日本癌学会学術総会
    • Place of Presentation
      横浜市
    • Year and Date
      2009-10-03
    • Related Report
      2009 Annual Research Report

URL: 

Published: 2009-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi